Survival rates for International Federation of Gynecology and Obstetrics stage III ovarian carcinoma by cell type: A study of 262 unselected patients with uniform pathologic review

International Journal of Gynecological Cancer

Volumn 22, Issue 3, 2012, Pages 367-371

  Seidman, Jeffrey D ^a   Yemelyanova, Anna ^b   Cosin, Jonathan A ^a   Smith, Anthony ^a   Kurman, Robert J ^b  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Carcinosarcoma; Clear cell carcinoma; Grade; Ovarian carcinoma; Serous carcinoma; Survival

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CARCINOMA; CARCINOMA CELL; CARCINOSARCOMA; CELL TYPE; CLEAR CELL CARCINOMA; CYTOREDUCTIVE SURGERY; ENDOMETRIOID CARCINOMA; FEMALE; GYNECOLOGIC SURGERY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; SEROUS CARCINOMA; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

CARCINOMA; COHORT STUDIES; FEMALE; GYNECOLOGY; HUMANS; INTERNATIONALITY; MIDDLE AGED; NEOPLASM STAGING; OBSTETRICS; ORGAN SPECIFICITY; OVARIAN NEOPLASMS; OVARY; RETROSPECTIVE STUDIES; SOCIETIES, MEDICAL; SURVIVAL RATE;

EID: 84863250697     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e31823c6f80     Document Type: Article

References (25)

1. Gilks CB, Ionescu DN, Kalloger SE, et al. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma. Hum Pathol. 2008;39:1239-1251.
2. Gilks CB. Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data. Int J Gynecol Pathol. 2004;23:200-205. (Pubitemid 38857108)
3. Yemelyanova AV, Cosin JA, Bidus MA, et al. Pathology of stage I versus stage III ovarian carcinoma with implications for pathogenesis and screening. Int J Gynecol Cancer. 2008;18:465-469. (Pubitemid 351668325)
4. Zorn KK, Bonome T, Gangi L, et al. Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer. Clin Cancer Res. 2005;11:6422-6430. (Pubitemid 41338978)
5. Kobel M, Kalloger SE, Boyd N, et al. Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med. 2008;5:e232.
6. Seidman JD, Cho KR, Ronnett BM, et al. Surface epithelial tumors of the ovary. In: Kurman RJ, Ellenson LH, Ronnett BM, eds. Blaustein's Pathology of the Female Genital Tract. 6th ed. New York: Springer; 2011:679-784.
7. Kobel M, Kalloger SE, Santos JL, et al. Tumor type and substage predict survival in stage I and II ovarian carcinoma: insights and implications. Gynecol Oncol. 2010;116:50-56.
8. Seidman JD, Horkayne-Szakaly I, Haiba M, et al. The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin. Int J Gynecol Pathol. 2004;23:41-44. (Pubitemid 38018236)
9. Soslow RA. Histologic subtypes of ovarian carcinoma: an overview. Int J Gynecol Pathol. 2008;27:161-174. (Pubitemid 351450675)
10. McCluggage WG. My approach to and thoughts on the typing of ovarian carcinomas. J Clin Pathol. 2008;61:152-163. (Pubitemid 351218874)
11. Han G, Gilks CB, Leung S, et al. Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases. Am J Surg Pathol. 2008;32:955-964.
12. Kurman RJ, Shih IM. Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol. 2008;27:151-160. (Pubitemid 351450677)
13. Gershenson DM, Sun CC, Lu KH, et al. Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary. Obstet Gynecol. 2006;108:361-368. (Pubitemid 44305678)
14. Seidman JD, Horkayne-Szakaly I, Cosin JA, et al. Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum. Gynecol Oncol. 2006;103:703-708. (Pubitemid 44602191)
15. Plaxe SC. Epidemiology of low-grade serous ovarian cancer. Am J Obstet Gynecol. 2008;198:459.e1-459.e9.
16. Malpica A, Deavers MT, Tornos C, et al. Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma. Am J Surg Pathol. 2007;31:1168-1174. (Pubitemid 47207118)
17. Malpica A, Deavers MT, Lu K, et al. Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol. 2004;28:496-504. (Pubitemid 38436523)
18. Schmeler KM, Gershenson DM. Low grade serous ovarian cancer: a unique disease. Curr Oncol Rep. 2008;10: 519-523.
19. Grimley PM, Matsuno RK, Rosenberg PS, et al. Qualitative age interactions between low grade and high grade serous ovarian carcinomas. Cancer Epidemiol Biomarkers Prev. 2009;18:2256-2261.
20. Ayhan A, Kurman RJ, Yemelyanova A, et al. Defining the cutpoint between low grade and high grade ovarian serous carcinomas: a clinicopathologic and molecular genetic analysis. Am J Surg Pathol. 2009;33:1220-1224.
21. Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet. 2011;377:127-138.
22. Yemelyanova AV, Cosin JA, Khedmati F, et al. Prognostic factors for stage I ovarian carcinoma. Int J Gynecol Pathol. 2010;29:1-7.
23. Takano M, Kikuchi Y, Yaegashi N, et al. Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging. Br J Cancer. 2006;94:1369-1374. (Pubitemid 43772268)
24. Heintz APM, Odicino F, Maisonneuve P, et al. Carcinoma of the ovary. 26th Annual report on the results of treatment in gynecological cancer. Int J Gynecol Obstet. 2006;95: S161-S192.
25. Chan JK, Teoh D, Hu JM, et al. Do clear cell ovarian carcinomas have a poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol. 2008;109:370-376.